Raluca Rusovici

608 total citations
9 papers, 498 citations indexed

About

Raluca Rusovici is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Raluca Rusovici has authored 9 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Ophthalmology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Raluca Rusovici's work include Retinal Diseases and Treatments (4 papers), Retinal Imaging and Analysis (2 papers) and Retinal Development and Disorders (2 papers). Raluca Rusovici is often cited by papers focused on Retinal Diseases and Treatments (4 papers), Retinal Imaging and Analysis (2 papers) and Retinal Development and Disorders (2 papers). Raluca Rusovici collaborates with scholars based in United States and Australia. Raluca Rusovici's co-authors include C. Chris Yun, Hyunsuk Shim, Kakarla V Chalam, K V Chalam, Sankarathi Balaiya, Holly LaVoie, Keyvan Koushan, Wenhua Li, Hong Sun and Dongsheng Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nutrients and American Journal of Physiology-Cell Physiology.

In The Last Decade

Raluca Rusovici

9 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raluca Rusovici United States 9 304 99 82 62 57 9 498
Yuta Ohno Japan 13 224 0.7× 110 1.1× 42 0.5× 68 1.1× 18 0.3× 39 480
Xielan Kuang China 13 227 0.7× 99 1.0× 31 0.4× 29 0.5× 25 0.4× 27 358
Caihong Huang China 13 161 0.5× 123 1.2× 22 0.3× 113 1.8× 18 0.3× 40 477
Ling Tang China 8 232 0.8× 50 0.5× 30 0.4× 14 0.2× 23 0.4× 16 391
Kuiyi Xing United States 11 332 1.1× 40 0.4× 8 0.1× 41 0.7× 49 0.9× 13 462
Zhigang Bi China 10 163 0.5× 24 0.2× 72 0.9× 15 0.2× 101 1.8× 10 417
Jürgen Frank Germany 8 210 0.7× 33 0.3× 122 1.5× 10 0.2× 18 0.3× 14 346
Xuerong Sun China 10 151 0.5× 36 0.4× 13 0.2× 19 0.3× 16 0.3× 27 304
Xia Miao China 13 186 0.6× 9 0.1× 37 0.5× 30 0.5× 10 0.2× 36 471
Liping Yang China 16 465 1.5× 165 1.7× 5 0.1× 42 0.7× 40 0.7× 44 625

Countries citing papers authored by Raluca Rusovici

Since Specialization
Citations

This map shows the geographic impact of Raluca Rusovici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raluca Rusovici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raluca Rusovici more than expected).

Fields of papers citing papers by Raluca Rusovici

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raluca Rusovici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raluca Rusovici. The network helps show where Raluca Rusovici may publish in the future.

Co-authorship network of co-authors of Raluca Rusovici

This figure shows the co-authorship network connecting the top 25 collaborators of Raluca Rusovici. A scholar is included among the top collaborators of Raluca Rusovici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raluca Rusovici. Raluca Rusovici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chalam, K V, et al.. (2013). Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle. Clinical ophthalmology. 7. 321–321. 12 indexed citations
2.
Koushan, Keyvan, et al.. (2013). The Role of Lutein in Eye-Related Disease. Nutrients. 5(5). 1823–1839. 104 indexed citations
3.
Chalam, K V, et al.. (2011). A Review: Role of Ultraviolet Radiation in Age-Related Macular Degeneration. Eye & Contact Lens Science & Clinical Practice. 37(4). 225–232. 93 indexed citations
4.
Rusovici, Raluca, et al.. (2011). Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cells.. PubMed. 17. 3339–46. 23 indexed citations
5.
Zhang, Huanchun, Agnieszka B. Bialkowska, Raluca Rusovici, et al.. (2007). Lysophosphatidic Acid Facilitates Proliferation of Colon Cancer Cells via Induction of Krüppel-like Factor 5. Journal of Biological Chemistry. 282(21). 15541–15549. 67 indexed citations
6.
Rusovici, Raluca, Amr M. Ghaleb, Hyunsuk Shim, Vincent W. Yang, & C. Chris Yun. (2007). Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(8). 1194–1203. 34 indexed citations
8.
Yun, C. Chris, Hong Sun, Dongsheng Wang, et al.. (2005). LPA2 receptor mediates mitogenic signals in human colon cancer cells. American Journal of Physiology-Cell Physiology. 289(1). C2–C11. 113 indexed citations
9.
Rusovici, Raluca & Holly LaVoie. (2003). Expression and Distribution of AP-1 Transcription Factors in the Porcine Ovary1. Biology of Reproduction. 69(1). 64–74. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026